Full name
M2M MED. SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 34 | -250,5 | -219 | 12,6 |
Gross profit (loss) | 36,4 | -246,2 | -168,3 | 31,6 |
EBITDA | 49,2 | -225,3 | -151,6 | 32,7 |
Short time liabilities | 479,7 | 470,2 | 558 | 18,7 |
Other operating costs | 0,1 | 2,1 | 3,7 | 79,9 |
Equity capital | 38 | -208,2 | -376,6 | -80,9 |
Operating profit (EBIT) | 36,4 | -245,9 | -167,9 | 31,7 |
Assets | 517,7 | 261,9 | 181,5 | -30,7 |
Net profit (loss) | 33 | -246,2 | -168,3 | 31,6 |
Cash | 39,1 | 85,2 | 1 | -98,8 |
Liabilities and provisions for liabilities | 479,7 | 470,2 | 558 | 18,7 |
Net income from sale | 309,4 | 93,7 | 36,1 | -61,5 |
Working assets | 362,9 | 118,4 | 54,2 | -54,2 |
Other income costs | 2,5 | 6,7 | 54,9 | 714,4 |
Depreciation | 12,8 | 20,5 | 16,3 | -20,5 |
% | % | % | p.p. | |
Profitability of capital | 86,8 | 118,3 | 44,7 | -73,6 |
Equity capital to total assets | 7,3 | -79,5 | -207,5 | -128 |
Gross profit margin | 11,8 | -262,7 | -466,8 | -204,1 |
EBITDA Margin | 15,9 | -240,4 | -420,4 | -180 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 566 | 1831 | 5648 | 3817 |
Current financial liquidity indicator | 0.7564106583595276 | 0.25180038809776306 | 0.09719432890415192 | -0,2 |
Net dept to EBITDA | 8.610756874084473 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane